Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

No tweets found

Recent Tweets for ALNY

MaisaCorp @MaisaCorp
$ALNY Completes Enrollment In Envision Phase 3 Study Of Givosiran- ON TRACK TO REPORT INTERIM ANALYSIS DATA BY END… https://t.co/Cg3dnb3u8h
August 21st 2018, 7:08pm
MareaInformativ @MareaInformativ
Goldman Sachs Group Lowers Alnylam Pharmaceuticals $ALNY to Buy https://t.co/VQMJJEkOlX
August 21st 2018, 5:08pm
dakotafinancial @dakotafinancial
Analysts Set Alnylam Pharmaceuticals, Inc. $ALNY Target Price at $142.00 https://t.co/yyuSTorN8T
August 21st 2018, 3:08pm
bibeypost_stock @bibeypost_stock
It Seems Alnylam Pharmaceuticals, Inc. $ALNY Will Go Down. Formed A Few Months Double Bottom Chart Pattern - https://t.co/ArdipA6hEz
August 21st 2018, 3:08pm
reurope_stock @reurope_stock
Alnylam Pharmaceuticals, Inc. $ALNY Could Burn Your Portfolio. The Stock Formed Bearish Double Bottom Chart Pattern https://t.co/zew5v82vRg
August 21st 2018, 3:08pm
mmahotstuff1 @mmahotstuff1
What's in Alnylam Pharmaceuticals, Inc. $ALNY After Forming Bearish Double Bottom Chart Pattern? - https://t.co/fLqRubLu1z
August 21st 2018, 3:08pm
whatsonthorold2 @whatsonthorold2
It Seems Alnylam Pharmaceuticals, Inc. $ALNY Will Go Down. Formed A Few Months Bearish Double Bottom Chart Pattern - https://t.co/r9R1ioyOyr
August 21st 2018, 3:08pm
west_moreland @west_moreland
Does Alnylam Pharmaceuticals, Inc. $ALNY Have Any Gas After Forming This Double Bottom Chart Pattern? https://t.co/g69PTCU5sH
August 21st 2018, 3:08pm
Fanob_stock @Fanob_stock
Could Alnylam Pharmaceuticals, Inc. $ALNY See a Reversal After Having Formed Several Months Double Bottom https://t.co/GWV49VyJOO
August 21st 2018, 3:08pm
usindexlive @usindexlive
Lord Abbett & Company Increases Holding in Alnylam Pharmaceuticals Com $ALNY; Grupo Aeroportuario Ctr Nort $OMAB St… https://t.co/uI9pFiy4CS
August 21st 2018, 3:08pm
EnterpriseLeade @EnterpriseLeade
Morgan Stanley Analysts Give Alnylam Pharmaceuticals $ALNY a $93.00 Price Target https://t.co/AHj8bGEjbO
August 21st 2018, 3:08pm
MareaInformativ @MareaInformativ
Stifel Nicolaus Reaffirms Buy Rating for Alnylam Pharmaceuticals $ALNY https://t.co/e2hNlUsJsx
August 21st 2018, 2:08pm
Singlemalt_18 @Singlemalt_18
12 month return for $IONS and $ALNY a virtual tie at +12.5% vs +14% How's that 80/20 advantage for patirisan vs inotersen workin' out?
August 21st 2018, 1:08pm
MarketCurrents @MarketCurrents
Alnylam competes enrollment in late-stage study of givosiran in AHP https://t.co/OTiV8tn8lH #premarket $ALNY
August 21st 2018, 11:08am
Amarshall7M @Amarshall7M
RT @odibro: $ALNY Completes Enrollment in ENVISION P3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of AHPs. In…
August 21st 2018, 11:08am
tabuhasna @tabuhasna
RT @BioStocks: $ALNY completes Enrollment in ENVISION Phase 3 Study of Givosiran for the Treatment of Acute Hepatic Porphyrias (AHPs). Int…
August 21st 2018, 11:08am
odibro @odibro
$ALNY Completes Enrollment in ENVISION P3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment… https://t.co/bLyIXLH9I6
August 21st 2018, 11:08am
BioStocks @BioStocks
$ALNY completes Enrollment in ENVISION Phase 3 Study of Givosiran for the Treatment of Acute Hepatic Porphyrias (AH… https://t.co/7eauBlsPqP
August 21st 2018, 11:08am
tt300z @tt300z
$ALNY - Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi https://t.co/oqUXU1ohLk
August 21st 2018, 11:08am
MaisaCorp @MaisaCorp
$ALNY Veristat Congratulates Alnylam on the FDA Approval of ONPATTRO(TM) (patisiran)
August 20th 2018, 4:08pm
CarlyHFierce @CarlyHFierce
ICYMI: Alnylam vows value-based pricing, financial help with $450K Onpattro launch https://t.co/t38oJvPEH5 $ALNY #pharma
August 20th 2018, 3:08pm
AmericanBanking @AmericanBanking
Weekly Analysts’ Ratings Updates for Alnylam Pharmaceuticals $ALNY https://t.co/sCavb2A8YF #stocks
August 20th 2018, 7:08am
TranscriptDaily @TranscriptDaily
Weekly Analysts’ Ratings Updates for Alnylam Pharmaceuticals $ALNY https://t.co/jUFEXwPRV8
August 20th 2018, 7:08am
RNAiAnalyst @RNAiAnalyst
$SLN stock up 17%...settlement in $ALNY to be announced on official EU approval? https://t.co/x9bnHAjsBZ
August 20th 2018, 7:08am
tgtxdough @tgtxdough
GS ESC CONFERENCE. 8/28. Focus is high on $PFE’s Tafamadis data&competitive read-through to $ALNY while we&others s… https://t.co/VacNaeRWcQ
August 19th 2018, 10:08pm
jbzstocks @jbzstocks
$ALNY -- Textbook stochastic divergence. Seems like a good time to breakout of the 20+ week base. https://t.co/aeNn1geKgx
August 19th 2018, 1:08pm
beyond_ninety @beyond_ninety
Alnylam Pharmaceuticals $ALNY Shares Declined While Sabby Management Has Cut Position; Expeditors Intl $EXPD Holder… https://t.co/B8JwUZ6yC2
August 19th 2018, 12:08pm
MareaInformativ @MareaInformativ
Alnylam Pharmaceuticals $ALNY Given New $99.00 Price Target at Morgan Stanley https://t.co/nNc38RzDpo
August 19th 2018, 12:08pm
usindexlive @usindexlive
Thornburg Investment Management Has Lifted Cognizant Tech Solutions $CTSH Stake; Alnylam Pharmaceuticals $ALNY's Se… https://t.co/h345gE4Hi6
August 19th 2018, 8:08am
themarketisopen @themarketisopen
$ALNY Here’s Why Alnylam’s Shares Are Tumbling https://t.co/dmu9WK4Eob
August 18th 2018, 10:08pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Brokerages https://t.co/BXv5gV1zI9 #stocks
August 18th 2018, 4:08pm
ConsumerFeed @ConsumerFeed
Alnylam Pharmaceuticals, Inc. $ALNY Receives Average Recommendation of “Buy” from Brokerages https://t.co/gtd872cOor
August 18th 2018, 4:08pm
usindexlive @usindexlive
Alnylam Pharmaceuticals $ALNY Shares Declined While Eventide Asset Management Has Trimmed Its Holding by $3.33 Mill… https://t.co/QiCC90OjA3
August 18th 2018, 11:08am
themarketisopen @themarketisopen
$ALNY Here’s Why Alnylam’s Shares Are Tumbling https://t.co/93oFm4lVaB
August 18th 2018, 7:08am
WeekHerald @WeekHerald
Q3 2018 Earnings Forecast for Alnylam Pharmaceuticals, Inc. Issued By Piper Jaffray Companies $ALNY https://t.co/3CPbbU6OqC
August 18th 2018, 1:08am
ThisLincolnian @ThisLincolnian
Q3 2018 Earnings Forecast for Alnylam Pharmaceuticals, Inc. Issued By Piper Jaffray Companies $ALNY https://t.co/07iOe54Agv
August 18th 2018, 1:08am
TranscriptDaily @TranscriptDaily
Zacks: Brokerages Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Earnings of -$1.78 Per Share https://t.co/EhT7AhPagE
August 17th 2018, 9:08pm
ZolmaxNews @ZolmaxNews
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $20.00 Million https://t.co/ODJIvIMTHc
August 17th 2018, 9:08pm
psuvafan007 @psuvafan007
Using $ALNY patisirin RNAi timeline as comparision, will first CRISPR drug gain approval faster or slower than 20 y… https://t.co/DmQZbP23hA
August 17th 2018, 11:08am
beyond_ninety @beyond_ninety
As Alnylam Pharmaceuticals Com $ALNY Stock Value Declined, Holder Canada Pension Plan Investment Board Has Decrease… https://t.co/Qyf9JLVgUQ
August 17th 2018, 10:08am
TRiMBio1 @TRiMBio1
@BagholderQuotes I got a bad case of the tutes, damn it $ALNY
August 17th 2018, 10:08am
portefeuillefun @portefeuillefun
Sold 100 $ALNY at $94.08, now 700 #vssporte shares.
August 17th 2018, 9:08am
RNAiAnalyst @RNAiAnalyst
2ndary outcomes for disease progression/reversal could have most impact on $alny https://t.co/JreEDcTBF2
August 17th 2018, 9:08am
WeekHerald @WeekHerald
Alnylam Pharmaceuticals $ALNY Stock Rating Lowered by Goldman Sachs Group https://t.co/1YqpPmL6vL
August 17th 2018, 8:08am
dakotafinancial @dakotafinancial
Stifel Nicolaus Reaffirms Buy Rating for Alnylam Pharmaceuticals $ALNY https://t.co/5SlIBbvkIS
August 17th 2018, 8:08am
ThisLincolnian @ThisLincolnian
Alnylam Pharmaceuticals $ALNY Stock Rating Lowered by Goldman Sachs Group https://t.co/gkOhsS3EMv
August 17th 2018, 8:08am
ZolmaxNews @ZolmaxNews
Alnylam Pharmaceuticals’ $ALNY Buy Rating Reaffirmed at Needham & Company LLC https://t.co/aLYiMmb5l7
August 17th 2018, 6:08am
TheMarketsDaily @TheMarketsDaily
B. Riley Increases Alnylam Pharmaceuticals $ALNY Price Target to $230.00 https://t.co/TKe85KBcbb
August 17th 2018, 6:08am
dailypoliticaln @dailypoliticaln
Morgan Stanley Analysts Give Alnylam Pharmaceuticals $ALNY a $93.00 Price Target https://t.co/mn1BYjshSR
August 17th 2018, 6:08am
MareaInformativ @MareaInformativ
BMO Capital Markets Trims Alnylam Pharmaceuticals $ALNY Target Price to $125.00 https://t.co/qVo150UPo0
August 17th 2018, 6:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.